--(BUSINESS WIRE)--Sedia Biosciences Corporation is a U.S.-based healthcare company focused on the development and commercialization of novel in vitro diagnostic and epidemiological tests and specimen collection devices. The company is dedicated to advancing access to medical care by developing innovative diagnostic and monitoring products that enable more cost effective and expanded testing for infectious diseases and other conditions.
| Company: | Sedia Biosciences Corporation | |
| Headquarters Address: | 4900 NE 122nd Ave | |
| Portland, OR 97230 | ||
| Main Telephone: | 503-459-4159 | |
| Website: | ||
| Type of Organization: | Private | |
| Industry: | Biotechnology | |
| Key Executives: | CEO: Roger Gale | |
| President: Ronald Mink | ||
| Public Relations | ||
| Contact: | Ronald Mink | |
| Phone: | 503-459-4159 | |
| Email: | ||
| Investor Relations | ||
| Contact: | Roger Gale | |
| Phone: | 503-459-4159 | |
| Email: |
